Trials / Not Yet Recruiting
Not Yet RecruitingNCT06863441
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study on the value of PET imaging targeting granzyme B in predicting the efficacy and prognosis of T-NK cell lymphoma.
Detailed description
The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo 68Ga-grazytracer PET at baseline and after one course of immunotherapy.
Conditions
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2029-12-31
- Completion
- 2029-12-31
- First posted
- 2025-03-07
- Last updated
- 2025-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06863441. Inclusion in this directory is not an endorsement.